DLB - Dolby Laboratories, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $1.34
|
Rev Est: $385.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$79.50
DETAILS
HIGH:
$85.00
LOW:
$74.00
MEDIAN:
$79.50
CONSENSUS:
$79.50
UPSIDE:
24.22%
Market Cap:
6.13B
Volume:
763,216
Avg Volume:
745,441
52 Week Range:
60.14-84.15
Sector:
Technology
Industry:
Information Technology Services
Beta:
0.85
Last Dividend:
$1.38
Exchange:
NYSE
Country:
US
Employees:
2,080
IPO Date:
2005-02-17
EPS (TTM):
2.66
P/E Ratio:
27.21
Revenue (TTM):
1.35B
Total Assets:
3.23B
Total Debt:
38.88M
Cash & Equiv:
701.89M
Rev Growth (5Y):
3.0%
EPS Growth (5Y):
2.9%
FCF Growth (5Y):
9.4%
ROCE:
10.0%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $1.06 | $0.99 | +6.7% | $346.7M | $341.3M | +1.6% |
| 2025-11-18 | $0.99 | $0.70 | +41.6% | $307.0M | $305.8M | +0.4% |
| 2025-07-31 | $0.78 | $0.72 | +8.3% | $315.5M | $305.8M | +3.2% |
| 2025-05-01 | $1.34 | $1.29 | +3.9% | $369.6M | $305.2M | +21.1% |
| 2025-01-29 | $1.14 | $1.07 | +6.5% | $357.0M | $383.8M | -7.0% |
| 2024-11-19 | $0.81 | $0.70 | +15.7% | $304.8M | $307.9M | -1.0% |
| 2024-08-07 | $0.71 | $0.59 | +20.3% | $288.8M | $307.9M | -6.2% |
| 2024-05-02 | $1.27 | $1.19 | +6.7% | $364.5M | $359.4M | +1.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.35B | 1.27B | 1.30B | 1.25B | 1.28B | 1.16B | 1.24B | 1.05B | 1.08B | 1.03B | 970.64M | 960.18M |
| Net Income | 255.02M | 261.82M | 200.66M | 184.09M | 310.23M | 231.36M | 255.15M | 41.75M | 201.80M | 185.86M | 181.39M | 206.10M |
| EPS | 2.66 | 2.74 | 2.00 | 1.84 | 3.07 | 2.30 | 2.51 | 1.18 | 1.98 | 1.85 | 1.75 | 2.02 |
| Total Assets | 3.23B | 3.13B | 2.99B | 2.70B | 3.12B | 2.94B | 2.82B | 2.87B | 2.54B | 2.32B | 2.13B | 1.98B |
| Total Debt | 38.88M | 46.99M | 50.65M | 50.94M | 72.12M | 81.14M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 701.89M | 577.75M | 817.97M | 628.37M | 1.23B | 1.08B | 805.59M | 925.25M | 634.37M | 519.76M | 534.86M | 570.61M |
| Operating Cash Flow | 472.20M | 327.25M | 367.08M | 318.58M | 447.75M | 343.85M | 327.67M | 352.20M | 377.79M | 360.06M | 309.38M | 361.55M |
| Free Cash Flow | 430.26M | 297.25M | 336.74M | 259.12M | 393.30M | 274.86M | 214.14M | 266.85M | 272.93M | 138.28M | 114.44M | 248.23M |
| FCF per Share | 4.49 | 3.11 | 3.52 | 2.59 | 3.89 | 2.73 | 2.11 | 2.58 | 2.68 | 1.37 | 1.12 | 2.43 |
| Book Value | 2.62B | 2.48B | 2.36B | 2.25B | 2.60B | 2.43B | 2.31B | 2.19B | 2.14B | 1.97B | 1.81B | 1.71B |
| Cash & ST Investments | 702.60M | 577.75M | 957.11M | 817.58M | 1.27B | 1.13B | 924.74M | 1.10B | 882.12M | 641.39M | 673.76M | 801.82M |
| ROC Equity | 0.10 | 0.11 | 0.09 | 0.08 | 0.12 | 0.10 | 0.11 | 0.02 | 0.09 | 0.09 | 0.10 | 0.12 |